This mechanism was mediated by activating the expression of the Tribbles-3 pseudokinase (TRIB3) gene.227 ABTL0812 was in clinical evaluation in phase 1/1b trial in advanced cancer patients (NCT02201823). Here, TRIB3 is linked to cancer.